Demant A/S WILLF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $50.26
- Day Range
- $50.49–50.49
- 52-Week Range
- $37.40–54.00
- Bid/Ask
- $44.08 / $46.39
- Market Cap
- $11.14 Bil
- Volume/Avg
- 20,644 / 5,395
Key Statistics
- Price/Earnings (Normalized)
- 30.76
- Price/Sales
- 3.46
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 1.21%
Company Profile
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and audio diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 21,623
- Website
- https://www.demant.com
Competitors
Valuation
|
Metric
|
WILLF
|
GN
|
SOON
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.76 | 32.67 | 21.41 |
Price/Book Value | 8.10 | 2.85 | 7.21 |
Price/Sales | 3.46 | 1.44 | 4.19 |
Price/Cash Flow | 17.93 | 11.87 | 19.80 |
Price/Earnings
WILLF
GN
SOON
Financial Strength
|
Metric
|
WILLF
|
GN
|
SOON
|
|---|---|---|---|
Quick Ratio | 0.84 | 0.48 | 0.76 |
Current Ratio | 1.37 | 0.65 | 1.29 |
Interest Coverage | 6.91 | 1.86 | 29.18 |
Quick Ratio
WILLF
GN
SOON
Profitability
|
Metric
|
WILLF
|
GN
|
SOON
|
|---|---|---|---|
Return on Assets (Normalized) | 8.40% | 0.30% | 11.96% |
Return on Equity (Normalized) | 28.27% | 1.10% | 30.61% |
Return on Invested Capital (Normalized) | 12.19% | 1.28% | 22.85% |
Return on Assets
WILLF
GN
SOON
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Fxgwdfs | Fzytb | $185.5 Bil | |
SYK
| Stryker Corp | Cffjyttdp | Cggf | $128.2 Bil | |
MDT
| Medtronic PLC | Gjqthfqfx | Gthbccr | $106.7 Bil | |
BSX
| Boston Scientific Corp | Lvbgfjjj | Txxjh | $99.0 Bil | |
DXCM
| DexCom Inc | Fcxblkqyj | Lhlx | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Knybjykq | Mdybbx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Yhjmxkthj | Ymmmn | $24.9 Bil | |
ALGN
| Align Technology Inc | Lycrwctl | Nwxhg | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Qckqbrpv | Gclkfqn | $18.9 Bil | |
PODD
| Insulet Corp | Cmxpbhqcy | Rqnqfjl | $11.7 Bil |